Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Circulating Tumor Cells (CTC) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global circulating tumor cells (CTC) market size reached US$ 9.54 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.24 Billion by 2027, exhibiting a growth rate (CAGR) of 10.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters. They have different biological phenotypes, such as epithelial, mesenchymal, and mixed epithelial-mesenchymal. CTC levels in a patient's blood can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the isolation, enrichment, and detection of CTC, such as immunocapture, size-based separation, density-based separation, and microscopy. It also has wide-ranging applications in liquid biopsy, cancer research, drug development, and clinical biomarkers.

Circulating Tumor Cells (CTC) Market Trends:

The increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth. CTC assists in the early identification and real-time monitoring of lung, breast, digestive tract, and prostate cancer. In line with this, the increasing utilization of CTC in patient screening for metastasis and preclinical studies of new cancer drugs is favoring the market growth. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global circulating tumor cells (CTC) market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on technology, application, product, specimen and end user.

Breakup by Technology:

  • CTC Detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis
     

Breakup by Application:

  • Clinical/Liquid Biopsy
    • Risk Assessment
    • Screening and Monitoring
  • Research
    • Cancer Stem Cell and Tumorigenesis Research
    • Drug/Therapy Development
       

Breakup by Product:

  • Kits and Reagents
  • Blood Collection Tubes
  • Devices and Systems
     

Breakup by Specimen:

  • Blood
  • Bone Marrow
  • Other Body Fluids
     

Breakup by End User:

  • Hospital and Clinics
  • Research and Academic Institutes
  • Diagnostic Centres
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Technology, Application, Product, Specimen, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global circulating tumor cells (CTC) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global circulating tumor cells (CTC) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the specimen?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global circulating tumor cells (CTC) market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Circulating Tumor Cells (CTC) Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Technology
    6.1    CTC Detection and Enrichment Method
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    CTC Direct Detection Methods
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    CTC Analysis
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Application
    7.1    Clinical/Liquid Biopsy
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Risk Assessment
           7.1.2.2 Screening and Monitoring
        7.1.3 Market Forecast
    7.2    Research
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 Cancer Stem Cell and Tumorigenesis Research
           7.2.2.2 Drug/Therapy Development
        7.2.3 Market Forecast
8    Market Breakup by Product
    8.1    Kits and Reagents
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Blood Collection Tubes
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Devices or Systems
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Specimen
    9.1    Blood
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Bone Marrow
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Other Body Fluids
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by End User
    10.1    Hospital and Clinics
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Research and Academic Institutes
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Diagnostic Centres
        10.3.1 Market Trends
        10.3.2 Market Forecast
11    Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12    SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15    Price Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    BioFluidica Inc
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
        16.3.2    Creatv MicroTech Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
        16.3.3    CytoLumina Technologies Corp.
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
        16.3.4    Fluxion Biosciences Inc.
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
        16.3.5    Greiner Bio-One International GmbH
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
        16.3.6    Ikonisys Inc
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
        16.3.7    Menarini Silicon Biosystems
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
        16.3.8    Miltenyi Biotec
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
        16.3.9    Qiagen N.V
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
        16.3.10    Rarecells Diagnostics
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
        16.3.11    Stemcell Technologies
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio

List of Figures

Figure 1: Global: Circulating Tumor Cells Market: Major Drivers and Challenges
Figure 2: Global: Circulating Tumor Cells Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Circulating Tumor Cells Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Circulating Tumor Cells Market: Breakup by Technology (in %), 2021
Figure 5: Global: Circulating Tumor Cells Market: Breakup by Application (in %), 2021
Figure 6: Global: Circulating Tumor Cells Market: Breakup by Product (in %), 2021
Figure 7: Global: Circulating Tumor Cells Market: Breakup by Specimen (in %), 2021
Figure 8: Global: Circulating Tumor Cells Market: Breakup by End User (in %), 2021
Figure 9: Global: Circulating Tumor Cells Market: Breakup by Region (in %), 2021
Figure 10: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Circulating Tumor Cells (CTC Analysis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Circulating Tumor Cells (CTC Analysis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Circulating Tumor Cells (Research) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Circulating Tumor Cells (Research) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Circulating Tumor Cells (Kits and Reagents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Circulating Tumor Cells (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Circulating Tumor Cells (Blood Collection Tubes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Circulating Tumor Cells (Blood Collection Tubes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Circulating Tumor Cells (Devices or Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Circulating Tumor Cells (Devices or Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Circulating Tumor Cells (Blood) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Circulating Tumor Cells (Blood) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Circulating Tumor Cells (Bone Marrow) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Circulating Tumor Cells (Bone Marrow) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Circulating Tumor Cells (Other Body Fluids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Circulating Tumor Cells (Other Body Fluids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Circulating Tumor Cells (Hospital and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Circulating Tumor Cells (Hospital and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Circulating Tumor Cells (Research and Academic Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Circulating Tumor Cells (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Circulating Tumor Cells (Diagnostic Centres) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Circulating Tumor Cells (Diagnostic Centres) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: North America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: North America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: United States: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: United States: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Canada: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Canada: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Asia-Pacific: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Asia-Pacific: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: China: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: China: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Japan: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Japan: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: India: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: India: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: South Korea: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: South Korea: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Australia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Australia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Indonesia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Indonesia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Europe: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Europe: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Germany: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Germany: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: France: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: France: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: United Kingdom: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: United Kingdom: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Italy: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Italy: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Spain: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Spain: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Russia: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Russia: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Latin America: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Latin America: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Brazil: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Brazil: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Mexico: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Mexico: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Others: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Middle East and Africa: Circulating Tumor Cells Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Middle East and Africa: Circulating Tumor Cells Market: Breakup by Country (in %), 2021
Figure 86: Middle East and Africa: Circulating Tumor Cells Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Global: Circulating Tumor Cells Industry: SWOT Analysis
Figure 88: Global: Circulating Tumor Cells Industry: Value Chain Analysis
Figure 89: Global: Circulating Tumor Cells Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Circulating Tumor Cells Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Circulating Tumor Cells Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 3: Global: Circulating Tumor Cells Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Circulating Tumor Cells Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 5: Global: Circulating Tumor Cells Market Forecast: Breakup by Specimen (in Million US$), 2022-2027
Table 6: Global: Circulating Tumor Cells Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 7: Global: Circulating Tumor Cells Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Circulating Tumor Cells Market: Competitive Structure
Table 9: Global: Circulating Tumor Cells Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4